Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $406.93 million. The enterprise value is $333.38 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IPSC has 180.06 million shares outstanding. The number of shares has increased by 10.05% in one year.
| Current Share Class | 180.06M |
| Shares Outstanding | 180.06M |
| Shares Change (YoY) | +10.05% |
| Shares Change (QoQ) | +0.95% |
| Owned by Insiders (%) | 3.19% |
| Owned by Institutions (%) | 25.12% |
| Float | 97.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.73 |
| Forward PS | n/a |
| PB Ratio | 1.24 |
| P/TBV Ratio | 3.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.97, with a Debt / Equity ratio of 0.27.
| Current Ratio | 5.97 |
| Quick Ratio | 5.82 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 5.79 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -5.98% and return on invested capital (ROIC) is -4.50%.
| Return on Equity (ROE) | -5.98% |
| Return on Assets (ROA) | -3.26% |
| Return on Invested Capital (ROIC) | -4.50% |
| Return on Capital Employed (ROCE) | -7.39% |
| Weighted Average Cost of Capital (WACC) | 12.13% |
| Revenue Per Employee | $1.40M |
| Profits Per Employee | -$122,821 |
| Employee Count | 78 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -68,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +318.52% in the last 52 weeks. The beta is 1.67, so IPSC's price volatility has been higher than the market average.
| Beta (5Y) | 1.67 |
| 52-Week Price Change | +318.52% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 48.15 |
| Average Volume (20 Days) | 1,279,871 |
Short Selling Information
The latest short interest is 10.29 million, so 5.71% of the outstanding shares have been sold short.
| Short Interest | 10.29M |
| Short Previous Month | 8.63M |
| Short % of Shares Out | 5.71% |
| Short % of Float | 10.51% |
| Short Ratio (days to cover) | 6.27 |
Income Statement
In the last 12 months, IPSC had revenue of $109.16 million and -$9.58 million in losses. Loss per share was -$0.11.
| Revenue | 109.16M |
| Gross Profit | 13.50M |
| Operating Income | -15.04M |
| Pretax Income | -9.65M |
| Net Income | -9.58M |
| EBITDA | -1.94M |
| EBIT | -15.04M |
| Loss Per Share | -$0.11 |
Full Income StatementBalance Sheet
The company has $117.11 million in cash and $43.57 million in debt, with a net cash position of $73.55 million or $0.41 per share.
| Cash & Cash Equivalents | 117.11M |
| Total Debt | 43.57M |
| Net Cash | 73.55M |
| Net Cash Per Share | $0.41 |
| Equity (Book Value) | 158.94M |
| Book Value Per Share | 1.82 |
| Working Capital | 100.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$103.88 million and capital expenditures -$848,000, giving a free cash flow of -$104.72 million.
| Operating Cash Flow | -103.88M |
| Capital Expenditures | -848,000 |
| Depreciation & Amortization | 13.10M |
| Net Borrowing | n/a |
| Free Cash Flow | -104.72M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
Gross margin is 12.36%, with operating and profit margins of -13.78% and -8.78%.
| Gross Margin | 12.36% |
| Operating Margin | -13.78% |
| Pretax Margin | -8.84% |
| Profit Margin | -8.78% |
| EBITDA Margin | -1.78% |
| EBIT Margin | -13.78% |
| FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.05% |
| Shareholder Yield | -10.05% |
| Earnings Yield | -2.35% |
| FCF Yield | -25.74% |
Analyst Forecast
The average price target for IPSC is $4.25, which is 88.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.25 |
| Price Target Difference | 88.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | -10.90% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -3.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.67 |
| Piotroski F-Score | 3 |
